The company’s new CEO announced layoffs that will affect about 7% of company’s workforce.
Read more about this post on BioPharmaDive
Trending
- BioHeartland Unveils Indiana’s New Bioscience Identity
- Empowering Patients: Who Really Controls Your Medical Data?
- Vistagen Welcomes Dr. Angel S. Angelov as New Chief Medical Officer
- Biotechnology: The Top Choice for Students Over Life Sciences
- Obesity Breakthroughs: Amgen’s Promising Pipeline and Upcoming Catalysts
- Cruise Ship Passengers Quarantined After Hantavirus Concerns
- Dyne Therapeutics Surges 40% as Biotech Fund Offloads $14 Million in Shares
- Natural Cervical Ripening to Prevent Pharmacological Induction of Labor – a Pilot Study.
